# Acitretin

## Neotigason 10mg

| TAH Drug Code      | [**ONEOT**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ONEOT)                                                                                                                                                                                                                                                                                                                              |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Severe forms of psoriasis & disorders of keratinization.                                                                                                                                                                                                                                                                                                                                                |
| Dosing             | Psoriasis Adult Initial daily dosage, 25mg or 30 mg for 2-4 weeks. Maintenance: 25-50mg for 6-8 weeks. Maximum: 75mg/day. Keratinization disorders the lowest dose treatment is required. Less than 20 mg/day, but not more than 50 mg/day. Child: Safety and efficacy for pediatric patients have not been established. use with caution, 0.5 mg/kg. Maximum: 35mg/day.                                |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                           |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                           |
| Contraindications  | Hepatic or renal impairment. Elevated blood lipid levels. Pregnancy, lactation. Women of childbearing potential.                                                                                                                                                                                                                                                                                        |
| Adverse Effects    | Dry lips & mouth, cheilitis, rhagades around mouth, dry mucous membranes. Thirst. Conjunctivitis, impaired night vision. Headache. Thinning of skin. Arthralgia, ostealgia, myalgia. Hyperostosis & extraskeletal calcification. Reversible increase of liver enzymes. Dermatologic: Alopecia (50-75%), Cheilitis, Dry skin, Mucous membrane dryness, Skin peeling disorder Ophthalmic: Night blindness |
| Pregnancy          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                         |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                            |

